DONATED ORGAN AS A SOURCE OF CYTOMEGALOVIRUS IN ORTHOTOPIC LIVER-TRANSPLANTATION

被引:23
作者
SUTHERLAND, S
BRACKEN, P
WREGHITT, TG
OGRADY, J
CALNE, RY
WILLIAMS, R
机构
[1] UNIV LONDON KINGS COLL HOSP,LIVER UNIT,LONDON SE5 8RX,ENGLAND
[2] ADDENBROOKES HOSP,DEPT SURG,CAMBRIDGE CB2 2QQ,ENGLAND
[3] ADDENBROOKES HOSP,CLIN MICROBIOL & PUBL HLTH LAB,CAMBRIDGE CB2 2QQ,ENGLAND
关键词
DONOR; TRANSPLANTATION; CMV ANTIBODY NEGATIVE PRETRANSPLANT;
D O I
10.1002/jmv.1890370304
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The importance.of the donated organ as a source of CMV was assessed in 120 patients following orthotopic liver transplant and the CMV infections that developed in these patients were graded by severity. Forty-four recipients were CMV antibody negative pre-transplant. Eighteen of these received organs from CMV antibody positive donors and 15 (83%) developed primary CMV infections, 13 (87%) of which were symptomatic. Twenty-six received organs from CMV antibody negative donors and only 2 (8%) became CMV positive post transplant (P < 0.001). These data suggest that there would be a considerable advantage in matching CMV antibody negative recipients with negative donors. Forty-five percent of secondary infections were asymptomatic compared with 12% of primary infections, and only 11% became disseminated compared with 53% of primary infections. The secondary infections that followed transplantation of an organ from a CMV antibody positive donor were more likely to be symptomatic and were more severe than those in patients who received seronegative livers.
引用
收藏
页码:170 / 173
页数:4
相关论文
共 12 条
[1]  
ACKERMANN JR, 1988, TRANSPLANT P, V20, P469
[2]   CYTOMEGALOVIRUS-INFECTION AND REINFECTION TRANSMITTED BY HEART-TRANSPLANTATION [J].
CHOU, SW .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05) :1054-1056
[3]  
COSIMI AB, 1990, ARCH SURG-CHICAGO, V125, P781
[4]  
DUMMER JS, 1990, REV INFECT DIS, V12, pS767
[5]  
FREISE CE, 1991, TRANSPLANT P, V23, P1498
[6]  
KALAYOGLU M, 1988, LANCET, V1, P617
[7]  
MUHLBACHER F, 1989, TRANSPLANT P, V21, P25
[8]  
OGRADY JG, 1988, LANCET, V2, P302
[9]  
RAKELA J, 1987, TRANSPL P, V19, P2399
[10]  
RUBIN RH, 1984, PROGR TRANSPLANTATIO, V1, P89